At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CELZ Creative Medical Technology Holdings, Inc.
Closed Juneteenth National Independence Day 06-18 16:00:00 EDT
2.23
-0.01
-0.45%
盘后2.36
+0.13+5.83%
18:33 EDT
High2.32Low2.21Vol96.56K
Open2.22D1 Closing2.24Amplitude4.91%
Mkt Cap8.24MTradable Cap7.20MTotal Shares3.70M
T/O217.03KT/O Rate2.99%Tradable Shares3.23M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Creative Medical advances Project PHOENIX burn pit exposure registry into nationwide AI-driven virtual data collection phase
Reuters  ·  06-16
Creative Medical advances Project PHOENIX burn pit exposure registry into nationwide AI-driven virtual data collection phase
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
GlobeNewswire  ·  06-16
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate
Benzinga  ·  05-09
Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-09
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26
Reuters  ·  05-09
Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26
Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview
Reuters  ·  05-06
Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview
Creative Medical knee data ‘highly positive,’ says Roth Capital
TIPRANKS  ·  04-28
Creative Medical knee data ‘highly positive,’ says Roth Capital
Creative Medical reports pilot study of Ultrasome meets priamry endpoint
TIPRANKS  ·  04-28
Creative Medical reports pilot study of Ultrasome meets priamry endpoint
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
GlobeNewswire  ·  04-28
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
Creative Medical Technology FY 2025 net loss rises 9% to USD 6 million on revenue down 46% to USD 6,000
Reuters  ·  03-21
Creative Medical Technology FY 2025 net loss rises 9% to USD 6 million on revenue down 46% to USD 6,000
Creative Medical Technology Holdings Inc expected to post a loss of 37 cents a share - Earnings Preview
Reuters  ·  03-11
Creative Medical Technology Holdings Inc expected to post a loss of 37 cents a share - Earnings Preview
BRIEF-Creative Medical Technology Holdings Achieves Second Who Inn Milestone
Reuters  ·  02-10
BRIEF-Creative Medical Technology Holdings Achieves Second Who Inn Milestone
Creative Medical Technology Holdings Achieves Second Who Inn Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
THOMSON REUTERS  ·  02-10
Creative Medical Technology Holdings Achieves Second Who Inn Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
Creative Medical Technology Holdings Achieves Second WHO INN Milestone for Cell Therapy Pipeline
Reuters  ·  02-10
Creative Medical Technology Holdings Achieves Second WHO INN Milestone for Cell Therapy Pipeline
Creative Medical Technology Reports Positive Interim Results for CELZ-201 in Chronic Lower Back Pain Trial
Reuters  ·  01-13
Creative Medical Technology Reports Positive Interim Results for CELZ-201 in Chronic Lower Back Pain Trial
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point With Positive Interim Data From Adapt Trial and Celz-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
THOMSON REUTERS  ·  01-13
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point With Positive Interim Data From Adapt Trial and Celz-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
Creative Medical Technology Holdings Secures Regulatory Approval for Burn Pit Initiative
Reuters  ·  01-06
Creative Medical Technology Holdings Secures Regulatory Approval for Burn Pit Initiative
Creative Medical Technology Holdings Inc. Held Annual Shareholder Meeting
Reuters  ·  2025-12-20
Creative Medical Technology Holdings Inc. Held Annual Shareholder Meeting
No data available

Introduction

Company Name.
Creative Medical Technology Holdings, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Issue price:
--